Some 80% of HPV-negative OSCC show inactivation of TP53, either through gene mutation, LOH or increased expression of MDM2; when HPV is present (oropharyngeal cancers), the HPV E6 viral oncoprotein attenuates p53 expression; in these circumstances, TP53 mutations are uncommon. Here, TP53 is linked to oropharynx cancer.